I know many of you are overwhelmed with often-conflicting information on the COVID-19 virus. As a doctor and researcher, the health of the bleeding disorder community is my highest priority. Every Friday, I will be sending you vetted, trusted…
Objective:
To evaluate efficacy of IB1001 for perioperative management of bleeding under surgical circumstances in hemophilia B patients.
Methods:
The efficacy of IB1001 for perioperative management has…
As a community, we know how important it is for people with bleeding disorders to maintain comprehensive health insurance.
Amid the uncertainty of the ongoing coronavirus emergency, we want to remind you that insurance options exist even for…
Novo Nordisk recently announced that they have “paused” three clinical trials for their investigational subcutaneous therapy concizumab. The therapy is developed using a synthetically produced (recombinant) antibody derived from a single cell clone…
NHF will be posting all communications from pharmaceutical companies regarding any potential affects that the COVID-19 pandemic could have on the manufacture and distribution of their products. If you have any questions about your particular product…
As we continue to monitor the COVID-19 outbreak in the US and around the world, we understand the uncertainty that it may bring to our community. I know that first and foremost on your mind is the health and safety of you, your family, and others…
The 2020 United Airlines Half Marathon has been cancelled due to concerns over transmission of COVID-19. The NY Road Runners Association, which organizes the yearly event, issued this statement.
“At New York Road Runners, the welfare of our…
Due to the recommendations of local government, in response to the COVID-19 virus and concerns with the use of mass transit, NHF's New York City staff will be working remotely until further notice. All NHF employees will continue to be available via…
As previously reported by HFA and NHF, Takeda announced the recall of two lots of VONVENDI von Willebrand factor (recombinant) 1,300 I.U. vials on February 25, 2020. HFA and NHF recognize that recalls can be very unsettling for many in the bleeding…
Our greatest asset at NHF is the community we serve, our family of staff and volunteers. We are aware of the general concerns in the community about the COVID-19 outbreak and how this may impact your decision to attend the educational conferences…